CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer
出版年份 2017 全文链接
标题
CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer
作者
关键词
Non-small cell lung cancer, miRNA, CD73, miR-30a-5p, EGFR
出版物
Molecular Cancer
Volume 16, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-02-03
DOI
10.1186/s12943-017-0591-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer
- (2015) Martin Turcotte et al. CANCER RESEARCH
- CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer
- (2015) B. G. Leclerc et al. CLINICAL CANCER RESEARCH
- miR-30-5p Functions as a Tumor Suppressor and Novel Therapeutic Tool by Targeting the Oncogenic Wnt/β-Catenin/BCL9 Pathway
- (2014) Jian-Jun Zhao et al. CANCER RESEARCH
- NT5E Mutations That Cause Human Disease Are Associated with Intracellular Mistrafficking of NT5E Protein
- (2014) Michel Fausther et al. PLoS One
- miR-205 Targets PTEN and PHLPP2 to Augment AKT Signaling and Drive Malignant Phenotypes in Non-Small Cell Lung Cancer
- (2013) J. Cai et al. CANCER RESEARCH
- Anti-CD73 therapy impairs tumor angiogenesis
- (2013) Bertrand Allard et al. INTERNATIONAL JOURNAL OF CANCER
- Anti-Human CD73 Monoclonal Antibody Inhibits Metastasis Formation in Human Breast Cancer by Inducing Clustering and Internalization of CD73 Expressed on the Surface of Cancer Cells
- (2013) M. G. Terp et al. JOURNAL OF IMMUNOLOGY
- miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT
- (2013) C-J Kao et al. ONCOGENE
- Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer
- (2013) J Wang et al. ONCOGENE
- Overexpression of CD73 in Prostate Cancer is Associated with Lymph Node Metastasis
- (2013) Qing Yang et al. PATHOLOGY & ONCOLOGY RESEARCH
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- (2013) Balázs Győrffy et al. PLoS One
- CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
- (2013) S. Loi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Purinergic signalling and cancer
- (2013) Geoffrey Burnstock et al. Purinergic Signalling
- Expression and clinical significance of CD73 and hypoxia-inducible factor-1α in gastric carcinoma
- (2013) Xiao-Xia Lu WORLD JOURNAL OF GASTROENTEROLOGY
- MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer
- (2012) Chun-Wen Cheng et al. BREAST CANCER RESEARCH AND TREATMENT
- NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity
- (2012) H Wang et al. BRITISH JOURNAL OF CANCER
- NT5E CpG island methylation is a favourable breast cancer biomarker
- (2012) C Lo Nigro et al. BRITISH JOURNAL OF CANCER
- Opportunities and challenges for anti-CD73 cancer therapy
- (2012) Bin Zhang Immunotherapy
- Meta-analysis of microRNA expression in lung cancer
- (2012) Urmo Võsa et al. INTERNATIONAL JOURNAL OF CANCER
- Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer
- (2012) Xiuling Zhi et al. IUBMB LIFE
- Production of Adenosine by Ectonucleotidases: A Key Factor in Tumor Immunoescape
- (2012) François Ghiringhelli et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- 5′-ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells
- (2012) Claudia Quezada et al. JOURNAL OF CELLULAR PHYSIOLOGY
- High expression of CD73 as a poor prognostic biomarker in human colorectal cancer
- (2012) Xian-Rui Wu et al. JOURNAL OF SURGICAL ONCOLOGY
- The double-edge sword effect of anti-CD73 cancer therapy
- (2012) John Stagg OncoImmunology
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis
- (2011) X. Tan et al. CLINICAL CANCER RESEARCH
- MicroRNA history: Discovery, recent applications, and next frontiers
- (2011) Maria I. Almeida et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo
- (2011) X-X He et al. ONCOGENE
- CD73 Expression as a Potential Marker of Good Prognosis in Breast Carcinoma
- (2011) Anna Supernat et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Extracellular adenosine triphosphate and adenosine in cancer
- (2010) J Stagg et al. ONCOGENE
- Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma
- (2009) Danit Lebanony et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Value of Mature MicroRNA-21 and MicroRNA-205 Overexpression in Non-Small Cell Lung Cancer by Quantitative Real-Time RT-PCR
- (2008) A. Markou et al. CLINICAL CHEMISTRY
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started